Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial.
Saved in:
| Title: | Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial. |
|---|---|
| Authors: | Rousel, Jannik1,2 (AUTHOR), Saghari, Mahdi1,3 (AUTHOR), Pagan, Lisa1,3 (AUTHOR), Nădăban, Andreea2 (AUTHOR), Gambrah, Tom1 (AUTHOR), Theelen, Bart4 (AUTHOR), de Kam, Marieke L.1 (AUTHOR), Haakman, Jorine1 (AUTHOR), van der Wall, Hein E. C.1 (AUTHOR), Feiss, Gary L.5 (AUTHOR), Niemeyer-van der Kolk, Tessa1 (AUTHOR), Burggraaf, Jacobus1,2,3 (AUTHOR), Bouwstra, Joke A.2 (AUTHOR), Rissmann, Robert1,2,3 (AUTHOR) rrissmann@chdr.nl, van Doorn, Martijn B. A.1,6 (AUTHOR) |
| Source: | International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 18, p14315. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16616596 |
|---|---|
| DOI: | 10.3390/ijms241814315 |
